Live Breaking News & Updates on Marinus Pharmaceuticals

Stay updated with breaking news from Marinus pharmaceuticals. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Autodesk, and Marinus and Encourages Investors to Contact the Firm - Autodesk (NASDAQ:ADSK), Marinus Pharma (NASDAQ:MRNS)

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of ....

United States , South Carolina , New York , Brandon Walker , Bragar Eagel Squire , Marion Passmore , Marinus Pharmaceuticals Inc , Autodesk Inc , Marinus Pharmaceuticals , Plaintiff Deadline , Class Period , Bragar Eagel ,

Bragar Eagel & Squire, P.C. Reminds Investors That Class

NEW YORK, June 14, 2024 (GLOBE NEWSWIRE) Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that. ....

United States , South Carolina , New York , Marion Passmore , Bragar Eagel Squire , Brandon Walker , Autodesk Inc , Marinus Pharmaceuticals Inc , Marinus Pharmaceuticals , Plaintiff Deadline , Class Period , Bragar Eagel ,

Law Offices of Howard G. Smith Announces Investigation of Marinus Pharmaceuticals, Inc. (MRNS) on Behalf of Investors

Shareholders with losses of $100,000 or more are encouraged to contact the firm.

. ....

United States , Bristol Pike , Howardg Smith , Marinus Pharmaceuticals Inc , Law Offices , Marinus Pharmaceuticals , Attorney Advertising ,

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Marinus Pharmaceuticals, Inc. (MRNS) on Behalf of Investors

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Marinus Pharmaceuticals, Inc. (MRNS) on Behalf of Investors
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Howardg Smith , Bristol Pike , Marinus Pharmaceuticals Inc , Law Offices , Announces Investigation , Marinus Pharmaceuticals , Attorney Advertising ,

Avidity Up 33% on Rare Muscle Disease Study Results - Arcutis Biotherapeutics (NASDAQ:ARQT), Heron Therapeutics (NASDAQ:HRTX)

Avidity Biosciences (NASDAQ: RNA) announced encouraging initial data from the phase I/II FORTITUDE study evaluating two doses of delpacibart braxlosiran (del-brax, or formerly AOC 1020) in facioscapulohumeral muscular dystrophy (FSHD), a rare genetic disease of the muscles. ....

United States , Marinus Pharmaceuticals , Arcutis Biotherapeutic , Heron Therapeutics , Arcutis Biotherapeutics , Earnings Of Marinus Pharmaceuticals , Society International Research Congress , Avidity Biosciences Inc , Avidity Bioscience , International Research Congress , Avidity Biosciences , Zacks Rank , Marinus Pharmaceutical , Heron Therapeutic ,